John Palcza

1.8k total citations
59 papers, 1.0k citations indexed

About

John Palcza is a scholar working on Physiology, Psychiatry and Mental health and Oncology. According to data from OpenAlex, John Palcza has authored 59 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 15 papers in Psychiatry and Mental health and 11 papers in Oncology. Recurrent topics in John Palcza's work include Migraine and Headache Studies (13 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Sleep and Wakefulness Research (8 papers). John Palcza is often cited by papers focused on Migraine and Headache Studies (13 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Sleep and Wakefulness Research (8 papers). John Palcza collaborates with scholars based in United States, Belgium and Israel. John Palcza's co-authors include Matthew D. Troyer, M. Gail Murphy, Hong Sun, Michael Robertson, Rebecca Blanchard, Janice Wahl, Eliav Barr, Eric Lawitz, Mark J. DiNubile and Marı́a Buti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

John Palcza

58 papers receiving 983 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Palcza United States	18	278	231	209	194	183	59	1.0k
Surya Gupta United States	12	111 0.4×	478 2.1×	112 0.5×	57 0.3×	79 0.4×	24	959
Véronique Lelong‐Boulouard France	15	66 0.2×	64 0.3×	23 0.1×	108 0.6×	44 0.2×	50	1.0k
Fangping He China	18	132 0.5×	95 0.4×	51 0.2×	143 0.7×	42 0.2×	56	920
Xiaodong Zhang China	15	73 0.3×	97 0.4×	81 0.4×	111 0.6×	22 0.1×	67	671
Alessandro Príncipe Spain	15	233 0.8×	53 0.2×	72 0.3×	227 1.2×	30 0.2×	51	783
Bradley J. Davis United States	17	97 0.3×	133 0.6×	18 0.1×	132 0.7×	34 0.2×	34	1.1k
Key‐Chung Park South Korea	17	136 0.5×	131 0.6×	17 0.1×	129 0.7×	20 0.1×	62	708
Todd L. Kiefer United States	20	16 0.1×	93 0.4×	41 0.2×	33 0.2×	22 0.1×	52	1.3k
Yasushi Miyagi Japan	22	120 0.4×	112 0.5×	23 0.1×	95 0.5×	87 0.5×	88	1.4k

Countries citing papers authored by John Palcza

Since Specialization

Citations

This map shows the geographic impact of John Palcza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Palcza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Palcza more than expected).

Fields of papers citing papers by John Palcza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Palcza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Palcza. The network helps show where John Palcza may publish in the future.

Co-authorship network of co-authors of John Palcza

This figure shows the co-authorship network connecting the top 25 collaborators of John Palcza. A scholar is included among the top collaborators of John Palcza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Palcza. John Palcza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bajwa, Ednan K., John Palcza, Hwa-ping Feng, et al.. (2022). Effects of an inhaled soluble guanylate cyclase (sGC) stimulator MK-5475 in pulmonary arterial hypertension (PAH). Respiratory Medicine. 206. 107065–107065. 9 indexed citations

Li, Chi‐Chung, John Palcza, Jialin Xu, et al.. (2019). Absence of Clinically Significant Drug Interactions With Coadministration of Ubrogepant and an Ethinyl Estradiol/Norgestimate Oral Contraceptive in Healthy Female Subjects: A Phase 1 Pharmacokinetic Analysis (P1.10-018). Neurology. 92(15_supplement). 1 indexed citations

Sun, Hong, John Palcza, Russell Rosenberg, et al.. (2015). Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease. Respiratory Medicine. 109(3). 416–426. 37 indexed citations

Buti, Marı́a, Stuart C. Gordon, Eli Zuckerman, et al.. (2015). Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE: Table 1.. Clinical Infectious Diseases. 62(1). 32–36. 77 indexed citations

Forns, Xavier, Stuart C. Gordon, Eli Zuckerman, et al.. (2015). Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent. Journal of Hepatology. 63(3). 564–572. 109 indexed citations

Stroh, Mark, John Palcza, Jacqueline B. McCrea, et al.. (2012). The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus. Cancer Chemotherapy and Pharmacology. 69(5). 1247–1253. 5 indexed citations

Chaitman, Bernard, Andrew P. Ho, Jason F. Rowe, et al.. (2012). A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina. Clinical Pharmacology & Therapeutics. 91(3). 459–466. 48 indexed citations

Blanchard, Rebecca, M. Gail Murphy, John Palcza, et al.. (2011). Effect of Telcagepant on Spontaneous Ischemia in Cardiovascular Patients in a Randomized Study. Headache The Journal of Head and Face Pain. 51(6). 954–960. 16 indexed citations

Han, Tae Hyung, Rebecca Blanchard, John Palcza, et al.. (2010). The Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult Subjects. PubMed. 3(4). 55–62. 9 indexed citations

10.

Chaitman, Bernard, Andrew P. Ho, Janice Rowe, et al.. (2010). THE CALCITONIN GENE-RELATED PEPTIDE RECEPTOR ANTAGONIST TELCAGEPANT DOES NOT REDUCE EXERCISE TOLERANCE IN PATIENTS WITH EXERCISE INDUCED MYOCARDIAL ISCHEMIA. Journal of the American College of Cardiology. 55(10). A100.E939–A100.E939. 4 indexed citations

11.

Iannone, Raffaele, John Palcza, John J. Renger, et al.. (2010). Acute Alertness-Promoting Effects of a Novel Histamine Subtype-3 Receptor Inverse Agonist in Healthy Sleep-Deprived Male Volunteers. Clinical Pharmacology & Therapeutics. 88(6). 831–839. 26 indexed citations

12.

Schueren, Bart Van der, Rebecca Blanchard, M. Gail Murphy, et al.. (2010). The potent calcitonin gene‐related peptide receptor antagonist, telcagepant, does not affect nitroglycerin‐induced vasodilation in healthy men. British Journal of Clinical Pharmacology. 71(5). 708–717. 30 indexed citations

13.

Han, Tae Hyung, Rebecca Blanchard, John Palcza, et al.. (2010). Single‐ and Multiple‐Dose Pharmacokinetics and Tolerability of Telcagepant, an Oral Calcitonin Gene‐Related Peptide Receptor Antagonist, in Adults. The Journal of Clinical Pharmacology. 50(12). 1367–1376. 29 indexed citations

14.

Hoon, Jan de, Caitlin S. MacLeod, John Palcza, et al.. (2009). Lack of significant pharmacodynamic interaction between telcagepant 600 mg and sumatriptan 100 mg. Cephalalgia. 29(12). 1349–1349. 5 indexed citations

15.

Palcza, John, William S. Denney, Tae Hyung Han, et al.. (2009). Blockade of Capsaicin-Induced Dermal Vasodilatation (CIDV) by MK-3207, a Calcitonin-Gene Related Peptide (CGRP) Receptor Antagonist for Acute Treatment of Migraine. Cephalalgia. 2 indexed citations

16.

Schueren, Bart Van der, Bruce E. Blanchard, Mike Murphy, et al.. (2009). Assessment of the effect of MK-0974, an oral CGRP antagonist, on the Hemodynamic Response to Sublingual Nitroglycerin in healthy volunteers. Cephalalgia. 29(1). 2 indexed citations

17.

Sinclair, Simon, Stefanie A. Kane, Bart Van der Schueren, et al.. (2009). Inhibition of capsaicin‐induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK‐0974). British Journal of Clinical Pharmacology. 69(1). 15–22. 70 indexed citations

18.

Sinclair, Simon, Inge De Lepeleire, Rebecca Blanchard, et al.. (2007). Inhibition of capsaicin-induced increase in dermal microvascular blood flow by the oral CGRP antagonist, MK-0974. Cephalalgia. 27(6). 738–739. 7 indexed citations

19.

Sinclair, Simon, Inge De Lepeleire, Stefanie A. Kane, et al.. (2007). MK-0974, a novel oral CGRP antagonist, exhibits similar pharmacokinetics during and between migraine attacks. Headache The Journal of Head and Face Pain. 47(5). 811–812. 7 indexed citations

20.

Schueren, Bart Van der, Jan de Hoon, Yingling Xu, et al.. (2007). MK-0974, an oral CGRP antagonist, inhibits capsaicin-induced vasodilation in the human skin. Basic & Clinical Pharmacology & Toxicology. 101. 33–34. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact